![]() |
This study aims to determine the maximum price at which HIV vaccination is cost-effective in the Thai healthcare setting. It also aims to identify the relative importance of vaccine characteristics and risk behavior changes among vaccine recipients to determine how they affect this cost-effectiveness. Download this publication |
Thursday, 06 January 2011 11:14
Is a HIV Vaccine a Viable Option and At What Price? An Economic Evaluation of Adding HIV Vaccination into Existing Prevention Programs in Thailand. Leelahavarong P, Teerawattananon Y, Werayingyong P, et al (2011)
Tagged under


